Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's Hybrozyme™ Technology 2024-11-11 08:07
Welcome to 2024 Chinese Congress of Holistic Integrative Oncology (2024 CCHIO)& 4th International Congress of the Asian Oncology Society (AOS2024) 2024-11-09 14:45
Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024 2024-11-08 22:00
Mabwell Reveals Encouraging Pre-clinical Data of 7MW4811 at the 15th World ADC Conference 2024-11-08 22:00
Samsung Biologics earns ISO certifications in recognition of business excellence 2024-11-08 20:00
Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-11-08 18:01
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease 2024-11-08 17:45
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial 2024-11-08 16:30
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards 2024-11-08 11:27
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC 2024-11-08 10:40
Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo (CIIE) 2024-11-08 10:04
Shanghai thriving as global investment hub 2024-11-08 09:34
Akeso Published Mechanism of Action for CLDN18.2/CD47 Bispecific Antibody AK132 for the First Time at SITC Annual Meeting 2024-11-08 08:20
What to see at the 7th China International Import Expo 2024-11-07 23:17
United Imaging Receives First Approval in Canada 2024-11-07 22:00
CARsgen® to Present Zevor-cel, CT071 and CT0590 at ASH 2024 Annual Congress 2024-11-06 21:50
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer 2024-11-06 20:00
MEGAROBO Unveils High-Content Cell Imaging System for Advanced Multidimensional Biological Analysis 2024-11-06 19:00
Minghui Pharmaceutical Announces Promising Initial Results from Phase I Clinical Trial of MHB039A, a Novel PD-1 x VEGF Bispecific Antibody, in Patients with Relapsed/Refractory Solid Tumors 2024-11-06 18:00
Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss 2024-11-06 15:41
1 2 3 4 5 6 800